Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians

https://doi.org/10.1016/j.jns.2011.02.032Get rights and content

Abstract

Background

Multiple sclerosis (MS) is determined by interactions between genes and environment and the influence of vitamin D adequacy has been proposed. Previous studies have shown that serum 25-hydroxyvitaminD (25(OH)D) levels are genetically influenced. Polymorphisms in vitamin D pathway genes are candidates for association with MS susceptibility.

Methods

MS patients (n = 1364) and their unaffected first-degree relatives (n = 1661) were ascertained through the Canadian Collaborative study. Seventy-one SNPs, across four genes [vitamin D receptor (VDR), 1-alpha-hydroxylase (CYP27B1) enzyme, vitamin D binding protein (DBP), 24-hydroxylase (CYP24)], were genotyped and tested for association with MS susceptibility using TDT in PLINK. Secondary analyses included stratification for HLA-DRB1*15 and parent of origin transmission effects.

Results

We found no significant association of vitamin D pathway genes with MS susceptibility after correction for multiple comparisons. However, the VDR Fok1 variant (rs2228570), selected for previously positive associations with MS susceptibility and 25(OH)D levels in MS patients showed marginally distorted transmission in DRB15-negative patients (p = 0.03). There was no evidence for differential maternal versus paternal allele transmission.

Conclusions

The findings fail to directly connect vitamin D metabolism genes to MS susceptibility, despite a large sample size and comprehensive gene coverage.

Introduction

MS risk is determined by gene–environment interaction and the association of higher MS prevalence in areas of lower ultra violet radiation (UVR) is well known [1]. The gradient of increasing MS risk with increasing latitude in both hemispheres parallels that for UVR distribution. The mechanism for the putative protective effect of UVR on MS risk is unclear but vitamin D remains the best candidate for mediating this effect [2]. Clinical observations consistent with this hypothesis include low serum concentrations of 25-hydroxyvitamin D [25(OH)D] in MS patients [3], [4], seasonal fluctuation in the timing of MS births [5], [6] and fluctuation in MS disease activity correlating with 25(OH)D seasonality [7]. Vitamin supplementation [8] and higher serum 25(OH)D concentrations in adulthood [9] were associated with reduced risk of MS in 2 US cohort studies. In addition, sunlight exposure through outdoor activity has shown an inverse correlation with MS susceptibility [10], [11], [12].

Accordingly, genes involved in Vitamin D metabolism and transport are potential candidates for affecting susceptibility to MS. The major genetic loci for MS susceptibility lie within the major histocompatibility complex (MHC), namely the HLA-DRB1*15 haplotype. HLA-DRB1 contains a vitamin D response element (VDRE) in its promoter region, which was shown to be completely conserved in the HLA-DRB1*15 promoter, as well as functional in vitro [13]. It is possible that variants in vitamin D receptor genes affect MS susceptibility indirectly by altering interaction at VDREs within the MHC regulatory region.

Vitamin D is transported in the circulation bound to proteins, ~ 88% of which are vitamin D binding proteins (DBP). It is then hydroxylated to 25-hydroxy-vitamin D [25(OH)D] in the liver. 25(OH)D is the main circulating metabolite of vitamin D and widely accepted as the best measure of vitamin D adequacy [14]. The rate limiting step in the activation of vitamin D is a second hydroxylation to 1,25-dihydroxyvitamin D (1,25(OH)2D) by cytochrome P450 enzymes, 1-alpha-hydroxylase (CYP27B1; [15], [16]). 24-hydroxylase enzymes (CYP24A1) degrade the active metabolite. Biological effects are exerted through 1,25(OH)2D binding to the VDR to alter gene expression in target genes [17]. The VDR-bound 1,25(OH)2D complex acts as a transcription factor to initiate gene transcription upon binding to VDREs[18]. Here we assessed common variants in the genes known to be responsible for these metabolic steps as potential candidates for influencing MS pathogenesis via their effect on vitamin D status.

The association of vitamin D-related genes and MS susceptibility has been previously studied. The findings are inconsistent, with some positive associations [19], [20], [21], [22], [23] and some negative or inconclusive ones [24], [25], [26], [27]. This inconsistency may in part be due to population stratification and in some cases insufficiently large sample sizes. Furthermore, many published studies are limited by lack of comprehensive gene coverage, many examining only the 4 RFLPs of the large VDR gene or a few select SNPs.

In addition to associations with MS susceptibility, these four genes have been studied with respect to regulation of serum 25(OH)D levels. Several studies have found that polymorphisms in VDR [22], [28], [29], CYP27B1 [28] and DBP [30] influence circulating 25(OH)D levels. Elucidating the potential role of vitamin D in MS etiology remains an attractive goal, as maintaining vitamin D sufficiency in populations at risk would be a straightforward and cost-effective target for intervention [31].

Section snippets

Subjects

All subjects used in the study were ascertained through the ongoing Canadian Collaborative Project on the Genetic Susceptibility to MS (CCPGSMS, [32]). Informed consent was obtained from all subjects and experiments performed for this investigation comply with current ethics and guidelines. A family-based approach was used to test for association of candidate genes and susceptibility. The dataset used comprised 739 families, consisting of sibling pair, parent–child, aunt–uncle–niece–nephew, and

Results

Seventy-one variants were genotyped in the dataset which included of 739 families consisting of 3037 individuals. All informative SNPs were analyzed for association with MS risk using PLINK (Table 1). Evidence for significant uneven transmission was observed in several VDR SNPs (rs1544410-Bsm1, rs11574077, rs12581281, rs3782905, rs3819545, rs757343), one CYP24A1 SNP (rs2244719), and one DBP SNP (rs1352845). However the positive findings all fell below the significance threshold after applying a

Discussion

MS results from the interplay of genetic and environmental factors, and compromised vitamin D status remains one of the most attractive proposed environmental factors [31]. Given the epidemiological and now genetic evidence, we have examined by a candidate gene approach those genes involved in the vitamin D endocrine system. Here we evaluated roles for CYP27B1, VDR, DBP, and CYP24A1 genetic variation in susceptibility to MS. Recent studies have shown that serum 25(OH)D levels are under genetic

Acknowledgments

SMO is funded by a Clarendon fund studentship. The MS Society of Canada Scientific Research Foundation funds the CCPGSMS.

References (47)

  • M.F. Holick

    Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis

    Am J Clin Nutr

    (2004)
  • A.G. Uitterlinden et al.

    Genetics and biology of vitamin D receptor polymorphisms

    Gene

    (2004)
  • M. Sinotte et al.

    Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women

    Am J Clin Nutr

    (2009)
  • E.D. Acheson et al.

    Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables

    Acta Psychiatr Scand

    (1960)
  • J. Nieves et al.

    High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

    Neurology

    (1994)
  • S. Ozgocmen et al.

    Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

    J Bone Miner Metab

    (2005)
  • C.J. Willer et al.

    Timing of birth and risk of multiple sclerosis: population based study

    Bmj

    (2005)
  • S. Sotgiu et al.

    Seasonal fluctuation of multiple sclerosis births in Sardinia

    J Neurol

    (2006)
  • A.F. Embry et al.

    Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

    Ann Neurol

    (2000)
  • K.L. Munger et al.

    Vitamin D intake and incidence of multiple sclerosis

    Neurology

    (2004)
  • K.L. Munger et al.

    Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

    Jama

    (2006)
  • M.T. Kampman et al.

    Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

    J Neurol

    (2007)
  • I.A. van der Mei et al.

    Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case–control study

    Bmj

    (2003)
  • Cited by (59)

    • Vitamin D mechanisms of protection in multiple sclerosis

      2023, Feldman and Pike's Vitamin D: Volume Two: Disease and Therapeutics
    • Vitamin D and the epidemiology of multiple sclerosis

      2023, Feldman and Pike's Vitamin D: Volume Two: Disease and Therapeutics
    • The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks

      2019, Journal of Neuroimmunology
      Citation Excerpt :

      This hydroxylation step in vitamin D metabolism, catalysed by the CYP27B1 gene, could be important subject of genetic polymorphic alterations. The involvement of CYP27B1 genetic variants in MS development has been suggested by several studies (Sundqvist et al., 2010; Simon et al., 2011; Cortes et al., 2013; Zhuang et al., 2015; Hadjigeorgiou et al., 2018), while in others no association was found (Simon et al., 2010; Orton et al., 2011; Skalli et al., 2017). Considering these results, it seems that the role of CYP27B1 gene in MS is influenced by many factors and can also include populational variations.

    • Vitamin D

      2019, Mosaic of Autoimmunity: The Novel Factors of Autoimmune Diseases
    View all citing articles on Scopus
    View full text